Publications by authors named "Consoli A"

Background: Data about the safety and the efficacy of flow diversion for distal anterior cerebral artery (DACA) aneurysms are limited. We present the largest multicenter analysis evaluating the outcomes of flow diversion in unruptured DACA aneurysm treatment.

Methods: Databases from 39 centers were retrospectively reviewed for unruptured DACA aneurysms treated with flow-diverting stents.

View Article and Find Full Text PDF

Individuals with neurodevelopmental disorders (NDDs) are more susceptible to developing severe or resistant mood disorders. However, they often face challenges in accessing specific treatments. To understand the barriers to treatment in this group, we conducted a secondary analysis of a multicenter observational study on 305 adolescents referred to specialized care (mean age 14.

View Article and Find Full Text PDF

Background: Patients with acute basilar artery occlusion (BAO) and low-to-moderate symptoms (National Institutes of Health Stroke Scale [NIHSS] < 10) are poorly represented in thrombectomy trials. Our objective is to compare thrombectomy and best medical management (BMT) in this population.

Methods: We compared data of all consecutive patients presenting with an initial NIHSS < 10 and acute symptomatic BAO included in two registries.

View Article and Find Full Text PDF

Background And Purpose: Vasospasm is a common iatrogenic event during mechanical thrombectomy (MT). In such circumstances, intra-arterial nimodipine administration is occasionally considered. However, its use in the treatment of iatrogenic vasospasm during MT has been poorly studied.

View Article and Find Full Text PDF

Background: Periprocedural antiplatelet treatment is a key determinant for the risk-benefit balance of emergent carotid artery stenting (eCAS) during stroke endovascular treatment (EVT). We aimed to assess the safety and efficacy profile of cangrelor compared with glycoprotein IIb/IIIa (GPIIb/IIIa) inhibitors or aspirin monotherapy.

Methods: Data were extracted from the Endovascular Treatment in Ischemic Stroke (ETIS) registry, a prospective nationwide observational registry of stroke EVT in France.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how different anesthesia techniques (general anesthesia vs. non-general anesthesia) affect outcomes in mechanical thrombectomy for stroke, with a focus on the location of the blood clot.
  • Researchers analyzed data from nearly 2800 patients, finding that general anesthesia did not lead to better overall outcomes but was linked to increased risk of complications in some cases.
  • The results suggest that the type of anesthesia used during mechanical thrombectomy should be chosen based on the specific location of the occlusion to enhance safety and effectiveness.
View Article and Find Full Text PDF

Aims/hypothesis: We compared the effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) on renal outcomes in individuals with type 2 diabetes, focusing on the changes in eGFR and albuminuria.

Methods: This was a multicentre retrospective observational study on new users of diabetes medications. Participant characteristics were assessed before and after propensity score matching.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to explore treatment strategies for tandem occlusions (TOs) during emergent carotid stenting in Italy, highlighting uncertainties in the best approach despite benefits from mechanical thrombectomy.
  • A survey of 66 centers yielded a response rate of 84.8%, revealing that most prefer a retrograde approach with a closed-cell stent and single antiplatelet therapy during deployment.
  • The findings indicate that practices for managing TOs are inconsistent across the Italian neurovascular community, emphasizing the need for more evidence to establish a standardized treatment protocol.
View Article and Find Full Text PDF

Introduction: It is unknown whether the influence of age on clinical outcomes post endovascular treatment (EVT) is similar in posterior circulation stroke (PCS) compared to anterior circulation stroke (ACS).

Methods: Data were extracted from the ETIS registry, a nationwide prospective, multicenter, observational registry for stroke EVT procedures in France. We included patients treated with EVT for PCS or ACS between January 2015 and August 2023.

View Article and Find Full Text PDF

Introduction: Recently, four randomized controlled trials (RCTs) have demonstrated the benefits of mechanical thrombectomy (MT) in patients with acute ischemic stroke (AIS) caused by anterior large vessel occlusion (LVO) and a large ischemic core at baseline (LIC). The purpose of this study was to investigate the features influencing the clinical outcome and the benefits of mechanical thrombectomy in this subgroup.

Methods: We conducted a multicenter retrospective aggregate cohort study of patients with AIS-LVO and a LIC, assessed with quantitative core volume measures, treated with MT between 2012 and 2019.

View Article and Find Full Text PDF

: Semaglutide is the unique once-daily oral glucagon-like receptor agonist presently available. Aims of this study were to describe clinical characteristics of patients with type 2 diabetes (T2D) initiating oral semaglutide, to assess its effects on glycemic control, body weight (BW) and its tolerability in routine clinical practice. : Electronic medical records from two Italian diabetes clinics were evaluated.

View Article and Find Full Text PDF

Background: Positive susceptibility vessel sign (SVS) in patients with acute ischaemic stroke has been associated with friable red blood cell-rich clots and more effective recanalisation using stent retrievers versus contact aspiration. We compared the safety and efficacy of stent retrievers plus contact aspiration (combined technique) versus contact aspiration alone as the first-line thrombectomy technique in patients with acute ischaemic anterior circulation stroke and SVS-positive occlusions.

Methods: Adaptive Endovascular Strategy to the Clot MRI in Large Intracranial Vessel Occlusion (VECTOR) was a prospective, randomised, open-label study with blinded evaluation.

View Article and Find Full Text PDF

Background And Objectives: IV tenecteplase is an alternative to alteplase before mechanical thrombectomy (MT) in patients with large-vessel occlusion (LVO) ischemic stroke. Little data are available on its use in patients with large ischemic core. We aimed to compare the efficacy and safety of both thrombolytics in this population.

View Article and Find Full Text PDF

Background: We evaluated the clinical and safety outcomes of emergent carotid artery stenting (eCAS) plus endovascular thrombectomy (EVT) among patients with anterior tandem lesion (TL) and large ischemic core (LIC).

Methods: This retrospective study included consecutive stroke patients enrolled in the Endovascular Treatment in Ischemic Stroke Registry in France between January 2015 and June 2023. We compared the outcomes of carotid stenting vs no stenting in tandem lesion with pre-treatment LIC (Alberta Stroke Program Early CT Score (ASPECTS) 3-5) and stenting in tandem lesion vs thrombectomy alone for isolated intracranial occlusions with pre-treatment LIC.

View Article and Find Full Text PDF

Intradural spinal cord arteriovenous shunts are challenging vascular lesions with poor prognosis if left untreated. Therapeutic options include endovascular treatment, microsurgery or a combined approach. Surgical approaches are more complex if the lesions are located anteriorly and supplied by the anterior spinal artery (ASA).

View Article and Find Full Text PDF
Article Synopsis
  • * New treatment options, like dual GLP-1 and GIP receptor agonists, are being developed to combat this rise, with tirzepatide being a prominent example.
  • * This document reviews the main ways that GIP/GLP-1 co-agonists work and discusses the clinical effects of tirzepatide based on various studies.
View Article and Find Full Text PDF

Introduction: We aimed to compare the effectiveness and cost-effectiveness profiles of glucagon-like peptide-1 receptor agonist (GLP-1-RA), sodium-glucose cotransporter 2 inhibitor (SGLT2i), and dipeptidyl peptidase-4 inhibitor (DPP-4i) compared with sulfonylureas and glinides (SU).

Research Design And Methods: Population-based retrospective cohort study based on linked regional healthcare utilization databases. The cohort included all residents in Lombardy aged ≄40 years, treated with metformin in 2014, who started a second-line treatment between 2015 and 2018 with SU, GLP-1-RA, SGLT2i, or DPP-4i.

View Article and Find Full Text PDF
Article Synopsis
  • Some patients with serious strokes can get better help from special treatments called EVT, but they need to get this treatment quickly.
  • New technology is allowing doctors to use robots to help with these treatments from far away, which means care can be given even in places that are not close to big hospitals.
  • For this robot help to work well, hospitals need to change how they do things and make sure they have good communication systems ready.
View Article and Find Full Text PDF
Article Synopsis
  • Pulsatile tinnitus (PT) can severely impact quality of life and may be caused by a condition called sigmoid/transverse sinus stenosis (STSS), which has been treated with stenting techniques.
  • A study involving 12 women with PT and STSS showed that a new stent called BosStent was successfully used, and patients reported complete symptom resolution within one month.
  • Follow-up assessments revealed significant improvements in quality of life scores, highlighting the need for further research to confirm the safety and effectiveness of this treatment in larger patient groups.
View Article and Find Full Text PDF

Background: The GLP-1 receptor agonist liraglutide is used to treat hyperglycemia in type 2 diabetes but is also known to induce weight loss, preserve the beta cell and reduce cardiovascular risk. The mechanisms underlying these effects are however still not completely known. Herein we explore the effect of liraglutide on markers of immune cell activity in a population of obese individuals with prediabetes or newly diagnosed type 2 diabetes mellitus.

View Article and Find Full Text PDF

This article memorializes Héctor Fernåndez-Álvarez (1944-2023). Héctor was an exceptional mentor, therapist, supervisor, professor, researcher, author, and leader, as well as a beloved brother, partner, father, and grandfather. The consummate renaissance person who embraced all manners of cultural expressions through an intentional wanderlust, he sought to understand all forms of human suffering and to alleviate senseless ones.

View Article and Find Full Text PDF

Background: Retrospective studies suggest the superiority of first-line contact aspiration (CA) thrombectomy over stent-retriever (SR) in basilar artery occlusions (BAO). We aimed to investigate the impact of first-line mechanical thrombectomy per the occlusion level, considering differences in stroke etiology prevalence between proximal and distal BAO.

Methods: A retrospective, multicentric analysis of the Endovascular Treatment in Ischemic Stroke Registry (ETIS) included consecutive BAO patients treated from January 2016 to May 2022.

View Article and Find Full Text PDF

While youths with intellectual disability (ID) have increased vulnerability for depressive disorders, cognitive problems and combined functional barriers make them less prone to receive adequate treatments. A systematic review of the literature was conducted (PROSPERO Registration number: CRD42022347703) based on several databases from 1980 to 2022 to examine the quality of tools for measuring depression in children and adolescents with ID. The COSMIN (COnsensus-based Standards for the selection of health status Measurement Instruments) checklist was used to assess several psychometric domains.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to compare the effectiveness of injectable versus oral semaglutide in managing type 2 diabetes by examining real-world clinical outcomes, including changes in HbA1c and body weight.
  • Researchers analyzed data from two matched groups of 107 participants each, finding that both formulations led to similar reductions in HbA1c and comparable weight loss after 18 months, although injectable users showed greater persistence with the medication.
  • The findings suggest that, in practical settings, both forms of semaglutide are effective for T2D management, but results may not apply universally to all patient populations due to specific characteristics of the cohorts studied.
View Article and Find Full Text PDF